Indexed in Journament

British journal of haematology

ISSN 1365-2141· EN

Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
39.8/100
Journament Score
#8,630
Journament Rank
11
Articles Indexed

About This Journal

Short Name Br J Haematol
Abbreviated Name british journal of haematology
ISSN 1365-2141

Indexings

scopus ncbi ulakbim sci

Tools & Certificate of Indexing

Certificate of Indexing
Quality Badge Widget - Embed on Your Website

Display your journal's verified indexing scores on your website with our self-contained widget.

One-Line JavaScript Embed:
Advantages: Single-line script, seamless DOM integration, clickable badges linking to full journal profile.
Standard iFrame Embed Code:
Widget Preview:

Publications Per Year

Articles (11)

2015
Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide
Arca M;Fardet L;Galicier L;Rivière S;Marzac C;Aumont C;Lambotte O;Coppo P;;
Vol. 168 , No. 1 , pp. -
471 views Abstract
2020
Analysis of saliva samples and cluster of differentiation 3 (CD3)+ lymphocytes as a source of germline DNA in myeloproliferative neoplasms.
Garcia-Gisbert, Nieves;Camacho, Laura;Fernández-Ibarrondo, Lierni;Fernández-Rodriguez, Concepcion;Longarón, Raquel;Gibert, Joan;Angona, Anna;Andrade-Campos, Marcio;Salar, Antonio;Besses, Carlos;Bellosillo, Beatriz;
441 views DOI
2020
Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial.
Stanworth, Simon J;Killick, Sally;McQuilten, Zoe K;Karakantza, Marina;Weinkove, Robert;Smethurst, Heather;Pankhurst, Laura A;Hodge, Renate L;Hopkins, Valerie;Thomas, Helen L;Deary, Alison J;Callum, Jeannie;Lin, Yulia;Wood, Erica M;Buckstein, Rena;Bowen, David;, ;
367 views DOI Abstract
2019
Low-dose methotrexate: potential clinical impact on haematological and constitutional symptoms in myeloproliferative neoplasms.
Francis, Sebastian;Thomas, Sally;Luben, Robert;Sousos, Nikolaos;Mead, Adam;Snowden, John A;Zeidler, Martin P;
366 views DOI
1999
Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy
E. Di Bona,F. Rodeghiero,B. Bruno,A. Gabbas,P. Foa,A. Locasciulli,C. Rosanelli,L. Camba,P. Saracco,A. Lippi,A. P. Iori,F. Porta,V. De Rossi,B. Comotti,P. Iacopino,C. Dufour,A. Bacigalupo;E. Di Bona;F. Rodeghiero;B. Bruno;A. Gabbas;P. Foa;A. Locasciulli;C. Rosanelli;L. Camba;P. Saracco;A. Lippi;A. P. Iori;F. Porta;V. De Rossi;B. Comotti;P. Iacopino;C. Dufour;A. Bacigalupo;
Vol. 107 , No. 2 , pp. 330-334
359 views DOI Abstract
2019
A journey through infectious risk associated with ruxolitinib.
Sant'Antonio, Emanuela;Bonifacio, Massimiliano;Breccia, Massimo;Rumi, Elisa;
Vol. 187 , No. 3 , pp. 286-295
357 views DOI Abstract
2020
Platelet biology of the rapidly failing lung.
Washington, A Valance;Esponda, Omar;Gibson, Angelia;
Vol. 188 , No. 5 , pp. 641-651
322 views DOI Abstract
2020
COVID19 coagulopathy in Caucasian patients
Fogarty, H.
Vol. 189 , pp. 1044-1049
289 views DOI
2019
Efficacy and safety of a bortezomib and reduced-intensity cytarabine-based protocol, TMC ALLR1, for relapsed childhood ALL in India
Roy, P.
, pp. 0-0
286 views DOI
1994
Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation.
Bensinger, W I;Longin, K;Appelbaum, F;Rowley, S;Weaver, C;Lilleby, K;Gooley, T;Lynch, M;Higano, T;Klarnet, J;
Vol. 87 , No. 4 , pp. 825-31
264 views Abstract
2024
CNS prophylaxis in large B-cell lymphomas: A balance with three pans.
Calimeri, Teresa;Ferreri, Andrés J M;
58 views DOI Abstract
2020
COVID19 coagulopathy in Caucasian patients
Fogarty, H.
Vol. 189 , pp. 1044-1049
289 views DOI
2020
Platelet biology of the rapidly failing lung.
Washington, A Valance;Esponda, Omar;Gibson, Angelia;
Vol. 188 , No. 5 , pp. 641-651
322 views DOI Abstract
2020
Analysis of saliva samples and cluster of differentiation 3 (CD3)+ lymphocytes as a source of germline DNA in myeloproliferative neoplasms.
Garcia-Gisbert, Nieves;Camacho, Laura;Fernández-Ibarrondo, Lierni;Fernández-Rodriguez, Concepcion;Longarón, Raquel;Gibert, Joan;Angona, Anna;Andrade-Campos, Marcio;Salar, Antonio;Besses, Carlos;Bellosillo, Beatriz;
441 views DOI
2020
Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial.
Stanworth, Simon J;Killick, Sally;McQuilten, Zoe K;Karakantza, Marina;Weinkove, Robert;Smethurst, Heather;Pankhurst, Laura A;Hodge, Renate L;Hopkins, Valerie;Thomas, Helen L;Deary, Alison J;Callum, Jeannie;Lin, Yulia;Wood, Erica M;Buckstein, Rena;Bowen, David;, ;
367 views DOI Abstract
2019
A journey through infectious risk associated with ruxolitinib.
Sant'Antonio, Emanuela;Bonifacio, Massimiliano;Breccia, Massimo;Rumi, Elisa;
Vol. 187 , No. 3 , pp. 286-295
357 views DOI Abstract
2019
Low-dose methotrexate: potential clinical impact on haematological and constitutional symptoms in myeloproliferative neoplasms.
Francis, Sebastian;Thomas, Sally;Luben, Robert;Sousos, Nikolaos;Mead, Adam;Snowden, John A;Zeidler, Martin P;
366 views DOI
2019
Efficacy and safety of a bortezomib and reduced-intensity cytarabine-based protocol, TMC ALLR1, for relapsed childhood ALL in India
Roy, P.
, pp. 0-0
286 views DOI
2015
Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide
Arca M;Fardet L;Galicier L;Rivière S;Marzac C;Aumont C;Lambotte O;Coppo P;;
Vol. 168 , No. 1 , pp. -
471 views Abstract
1999
Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy
E. Di Bona,F. Rodeghiero,B. Bruno,A. Gabbas,P. Foa,A. Locasciulli,C. Rosanelli,L. Camba,P. Saracco,A. Lippi,A. P. Iori,F. Porta,V. De Rossi,B. Comotti,P. Iacopino,C. Dufour,A. Bacigalupo;E. Di Bona;F. Rodeghiero;B. Bruno;A. Gabbas;P. Foa;A. Locasciulli;C. Rosanelli;L. Camba;P. Saracco;A. Lippi;A. P. Iori;F. Porta;V. De Rossi;B. Comotti;P. Iacopino;C. Dufour;A. Bacigalupo;
Vol. 107 , No. 2 , pp. 330-334
359 views DOI Abstract
40
Overall
Poor
31
15
30
40
38
50
0
0
0
0
0
Journament

Overall Quality Score

39.8/100

Tier: Poor

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

30.5/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

15.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

38.0/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

50.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Ethics & Transparency Score

0.0/100

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

0.0/100

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

0.0/100

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

0.0/100

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

0.0/100

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.